Camille Farhat Net Worth

The estimated Net Worth of Camille Farhat is at least $4.21 Milión dollars as of 10 December 2018. Camille Farhat owns over 11,516 units of RTI Surgical stock worth over $3,433,383 and over the last 11 years Camille sold RTIX stock worth over $773,224.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Camille Farhat RTIX stock SEC Form 4 insiders trading

Camille has made over 6 trades of the RTI Surgical stock since 2015, according to the Form 4 filled with the SEC. Most recently Camille bought 11,516 units of RTIX stock worth $44,337 on 10 December 2018.

The largest trade Camille's ever made was buying 83,000 units of RTI Surgical stock on 17 February 2017 worth over $285,520. On average, Camille trades about 15,892 units every 98 days since 2014. As of 10 December 2018 Camille still owns at least 1,093,434 units of RTI Surgical stock.

You can see the complete history of Camille Farhat stock trades at the bottom of the page.

What's Camille Farhat's mailing address?

Camille's mailing address filed with the SEC is C/O AMERICAN MEDICAL SYSTEMS, 10700 BREN ROAD WEST, MINNETONKA, MN, 55343.

Insiders trading at RTI Surgical

Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper a Terry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.

What does RTI Surgical do?

RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.

Complete history of Camille Farhat stock trades at Endo International plc a RTI Surgical

RTI Surgical executives and stock owners

RTI Surgical executives and other stock owners filed with the SEC include:

• Jonathon Singer,
  Chief Financial Officer, Chief Operating Officer
• John Varela,
  Executive Vice President - Global Operations
• Olivier Visa,
  Vice President - OEM, Sports and Donor Services
• Shirley Weis,
  Independent Director
• Thomas McEachin,
  Independent Director
• Mark Stolper,
  Lead Independent Director
• Paul Thomas,
  Independent Director
• Nicholas Valeriani,
  Independent Director
• Pawel Lewicki,
  Director
• Scott Durall,
  Chief Commercial Officer
• Bryan Cornwall,
  Executive Vice President - Research and Clinical Affairs
• Stuart Simpson,
  Chairman of the Board
• Molly Poarch,
  Director, Corporate Communications & Investor Relations
• Jeffrey Lightcap,
  Independent Director
• Brian Kushner,
  Director
• Ryan Bartolucci,
  Vice President - Finance, Corporate Controller
• Terry Rich,
  President, Chief Executive Officer, Director
• Lyle P. Luedeman,
  
• Dean H Bergy,
  Director
• Street Healthcare Partners ...,
  
• Christopher R Sweeney,
  Director
• Curtis M Selquist,
  Director
• Peter F Gearen,
  Director
• Brian K Hutchison,
  Chairman, President and CEO
• Camille Farhat,
  Chief Executive Officer
• Robert P Jordheim,
  Executive Vice President/CFO
• Roger W Rose,
  Vice President Donor Services
• Johannes Wynand Louw,
  Vice President Finance
• Kevin D Brandt,
  EVP CCO-Domestic Direct
• Joshua H De Rienzis,
  General Counsel
• Philip R Chapman,
  Director
• Ned Hoye Villers,
  Director
• Adrian J R Smith,
  Director
• Caroline A Hartill,
  V.P. Quality Assurance
• Julianne M Bowler,
  Director
• Roy D Crowninshield,
  Director
• Gregory P Rainey,
  Director
• Neal B Freeman,
  Director
• Michael J La Prade,
  Vice President
• Holdings Inc Zimmer,
  10% owner
• Roderick N Allen,
  Vice President
• David J Simpson,
  Director
• Guy L Mayer,
  President
• Michael J Odrich,
  Director
• Lee Robert Jr Johnston,
  Vice President
• Udo Henseler,
  Director
• Christie J Blakely,
  Vice President
• Robert J Lane,
  Vice President
• Tara Leigh Zerby,
  VP, Xenograft Technologies
• Carolyn Shaffer,
  Vice President, Human Resource
• Thomas F Rose,
  Vice President and CFO
• Michael T Manley,
  Director
• Louis E Barnes,
  Vice President-Cardiovascular
• Charles Randal Mills,
  V.P. of Business Development
• William Melendez,
  Vice President, Research & Dev
• Jeffrey Michael Schumm,
  Vice Pres. and General Counsel
• Joseph W Condon,
  Vice President-Operations